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Background: Nonphotosensitive trichothiodystrophy (TTDN) is a rare autosomal recessive disorder of neuroectodermal
origin. The condition is marked by hair abnormalities, intellectual impairment, nail dystrophies and susceptibility to
infections but with no UV sensitivity.
Methods: We identified three consanguineous Pakistani families with varied TTDN features and used homozygosity
mapping, linkage analysis, and Sanger and exome sequencing in order to identify pathogenic variants. Haplotype
analysis was performed and haplotype age estimated. A splicing assay was used to validate the effect of the MPLKIP
splice variant on expression.
Results: Affected individuals from all families exhibit several TTDN features along with a heart-specific feature, i.e. mitral
regurgitation. Exome sequencing in the probands from families ED168 and ED241 identified a homozygous splice
mutation c.339 + 1G > A within MPLKIP. The same splice variant co-segregates with TTDN in a third family ED210.
The MPLKIP splice variant was not found in public databases, e.g. the Exome Aggregation Consortium, and in unrelated
Pakistani controls. Functional analysis of the splice variant confirmed intron retention, which leads to protein truncation
and loss of a phosphorylation site. Haplotype analysis identified a 585.1-kb haplotype which includes the MPLKIP
variant, supporting the existence of a founder haplotype that is estimated to be 25,900 years old.
Conclusion: This study extends the allelic and phenotypic spectra of MPLKIP-related TTDN, to include a splice
variant that causes cardiomyopathy as part of the TTDN phenotype.
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Trichothiodystrophy (TTD) is an autosomal recessive dis-
order characterized by dry and easily broken brittle hair.
Hair lacks sulfur, an element that normally gives hair its
strength. The signs and symptoms of TTD vary widely;
mild cases may involve only hair and in more severe cases
additional features include intellectual disability, dwarfism,
microcephaly, abnormal facial features, premature aging,
ichthyosis, nail dystrophies, infertility and proneness to re-
spiratory infections [1]. TTD is divided into two forms i.e.
photosensitive (TTD1-3) and nonphotosensitive (TTD4
or TTDN1; MIM 234050) based on the presence or ab-
sence of clinical and cellular photosensitivity, respectively.
Majority of the photosensitive TTD patients have defects
in nucleotide excision repair pathway genes. ERCC2 (MIM
126340) variants cause TTD1 (MIM 601675) and are also
responsible for cerebrooculofacioskeletal syndrome (MIM
610756) and xeroderma pigmentosum group D (XPD;
MIM 278730) [2]. Variants in ERCC3 (MIM 133510) cause
not only TTD2 (MIM 616390) but also xeroderma pigmen-
tosum complementation group B (XPB; MIM 610651) [3].
Autosomal recessive variants in GTF2H5 (MIM 608780)
underlie TTD3 (MIM 616395) [4]. These genes encode
different subunits of the general transcription factor IIH
(TFIIH), which is also involved in global genome repair and
transcription-coupled repair. For nonphotosensitive TTDN
only causal mutations in the MPLKIP (MIM 609188) gene
have been reported [5]. MPLKIP consists of two coding
exons on chromosome 7p14.1 that encode nucleus-
restricted Plk1-interacting protein, and has ubiquitous
expression in brain, heart, lung, placenta, epidermis
and hair follicles, among others [5, 6]. The precise
function of MPLKIP has not yet been elucidated but its
nuclear localization signifies its role as a transcriptional
regulator of genes relevant for metabolic pathways that
are central to the outcome of TTDN1 [5].
In the present study, we identified three consanguineous
Pakistani families displaying features of TTDN. Linkage
analysis and homozygosity mapping coupled with exome
sequencing identified a splice site variant c.339 + 1G >A in
MPLKIP that segregates with TTDN in three families. The
expression of MPLKIP in constructs carrying the splice
variant in HEK293 cells confirmed unusual splicing, which
results in an abnormal protein product. Additionally mitral
regurgitation was identified in all affected individuals,
expanding the TTDN1 spectrum caused by MPLKIP
variants.
Methods
Recruitment of human subjects and clinical examination
Approval of the study was obtained from the Institutional
Review Boards of: Quaid-i-Azam University, Islamabad,
Pakistan; Baylor College of Medicine and Affiliated Hospi-
tals, Houston, Texas, USA; and Center for MedicalGenetics, Ghent University Hospital, Ghent, Belgium. Writ-
ten informed consent was obtained from the patient and all
family members for publication of genetic data, clinical
findings and any accompanying images. Copies of the writ-
ten consent were made available to this journal’s Editor for
review. The three families ED168, ED210 and ED241 were
recruited from rural areas of Khyber Pakhtunkhwa prov-
ince, Pakistan. The pedigree structures (Figs. 1a, 2a and d)
provided convincing evidence of an autosomal recessive
mode of inheritance of TTDN. Affected members of these
families underwent a complete physical examination and 2-
D echocardiogram at a local government hospital.
DNA extraction and genotyping
DNA was extracted from venous blood samples collected
from four affected and four unaffected members of family
ED168 (Fig. 1a), two affected and four unaffected mem-
bers of family ED210 (Fig. 2a) and three affected and four
unaffected members of family ED241 (Fig. 2d). Eight DNA
samples from family ED168 were submitted for whole-
genome scan using the Infinium® HumanCoreExome Chip
(Illumina, USA), which consists of >500,000 SNP markers.
Homozygosity mapping and linkage analysis were per-
formed using HomozygosityMapper and MERLIN, respect-
ively [7, 8]. Multipoint linkage analysis was performed
using a disease allele frequency of 0.001 and an autosomal
recessive mode of inheritance with complete penetrance.
Allele frequencies for SNP markers were estimated using
founders and reconstructed founders from 16 Pakistani
families genotyped using the same array. The genetic map
positions were based on the Rutgers combined linkage-
physical map (NCBI, GRCh37/hg19) [9].
Exome and Sanger sequencing
Exome sequencing was carried out using two DNA sam-
ples, the affected female IV-1 from family ED168 (Fig. 1a)
and the affected male individual IV-2 from family ED241
(Fig. 2d). For ED168 IV-1, sequence capture was performed
in solution with the Roche NimbleGen SeqCap EZ Human
Exome Library v2.0 to target approximately 36.6 Mb of
coding region. Subsequently the captured regions were
sequenced on an Illumina HiSeq. FASTQ files were aligned
to the human reference sequence (hg19) by using Burrows-
Wheeler Aligner [10]. The Genome Analysis Toolkit
(GATK) was used for realignment of regions contain-
ing indels, recalibration of base qualities, and variant
detection and calling [11]. The variant sites were an-
notated using SeattleSeq137.
For ED241 IV-2, exome capture was carried out using
the SureSelectXT Human All Exon V5 Enrichment Kit
(Agilent, Santa Clara CA, USA) and sequencing was per-
formed on a NextSeq 500 platform with paired-end 150-
bp reads. The CLC Genomics Workbench v7.0.3 (CLC
Bio, Qiagen, Aarhus, Denmark) software was used for
Fig. 1 a Pedigree of consanguineous Pakistani family ED168 showing co-segregation of TTDN with the SNP haplotype including the MPLKIP
c.339 + 1G > A variant. A DNA sample from the proband IV-1 was submitted for exome sequencing. The left panel lists the SNP markers and
corresponding hg19 physical positions on chromosome 7. b Chromatograms showing the splice variant as homozygous in an affected individual
and heterozygous or wild type in unaffected individuals. c Affected individual IV-2 (35 years old) has cataract and corneal bulging on the left eye,
absent eyelashes, sparse eyebrows, patchy hair loss on scalp and toenail dystrophy with grooved ridges. Scalp hair examination with light microscopy
shows characteristic tiger tail pattern. Echocardiogram from individual IV-2 revealed extra downward peaks, suggestive of mitral regurgitation.
d Affected individual IV-4 (27 years old) has sparse eyebrows, eyelashes and facial and leg hair. He also has irregular teeth with hypodontia
and dystrophic nails with grooved ridges. e cDNA analyses of the wild type transcript (lane W, 585 bp) and mutated MPLKIP transcript (lane M,
1569 bp) expressed in HEK293 cells, as compared to lane L showing the 2-Log DNA Ladder. The position of 500 bp and 1500 bp products in
ladder is marked with arrows
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quence (hg19), duplicate read removal, coverage analysis,
and variant calling. Variants were annotated with an in-
house software package, which makes use of the EnsemblAPI and Alamut Batch. To reduce the number of variants,
synonymous variants with no predicted splice site disrup-
tion, variants with an allelic frequency in the global 1000
Genomes population >10 % and technical variants (i.e.
Fig. 2 a Pedigree of a consanguineous Pakistani family ED210 showing co-segregation of TTDN with the 4.13-Mb haplotype that includes the
MPLKIP c.339 + 1G > A variant and four SNPs. The haplotype in family ED210 is included within the haplotype from family ED168. b Affected
individual IV-3 (17 years old) has sparse eyebrows and eyelashes, crooked beaked nose, flat malar eminences, retrognathia, patchy hair loss on
scalp, and nail dystrophy. c Aside from hair abnormalities, the proband IV-4 (8 years old) also has hypodontia and irregular teeth. The echocardiogram
from IV-4 shows mitral regurgitation. d Pedigree of third family, ED241 showing co-segregation of TTDN with the MPLKIP c.339 + 1G > A
variant. The affected individuals IV-1 (e) and IV-2 (f) show sparse to absent eyebrows and eyelashes, brittle and sparse hairs on scalp and
dystrophic toenails. The echocardiogram from IV-1 (e) also shows mitral regurgitation
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ection) were filtered out. The possible impact of vari-
ants on the protein level and on the correct splicing
was further assessed by Alamut [12], PolyPhen-2 [13],
and SIFT [14].
The exome sequence data for families ED168 and ED241
were independently analyzed focusing on the linkage region
for family ED168. Occurrence of homozygous variants was
checked in public databases [dbSNP, 1000 Genomes,
Exome Variant Server (EVS), Exome Aggregation Con-
sortium (ExAC)] and exome sequence data of 218 unre-
lated Pakistani individuals who have various Mendelian
traits but not TTDN. Functional annotation was per-
formed using the Combined Annotation Dependent
Depletion (CADD) [15] and dbNSFP [16].Sanger sequencing was performed to confirm co-
segregation of a homozygous splice site variant in in-
tron 1 of MPLKIP (NM_138701.3) with TTDN using
eight and seven DNA samples from families ED168 and
ED241, respectively, and primers 5/ GTACGGCTCTGC-
CACTCTTT 3/ and 5/ CGTACGGGAGCAGTCACTC 3/.
When family ED210 was identified, all DNA samples that
are available from family members were sequenced for the
two coding exons of MPLKIP. In four individuals from
family ED210 (Fig. 2a), additional SNP markers close to
theMPLKIP splice variant were Sanger-sequenced in order
to verify the occurrence of a founder haplotype. To deter-
mine the presence of the MPLKIP splice variant within the
general population, DNA samples from 142 Pakistani con-
trol individuals were also sequenced.
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Genotypes for the MPLKIP variant and 14 SNPs within a
585.1-kb haplotype which are homozygous in the two
exomes from ED168 and ED241 were examined in 218 in-
house exomes from unrelated Pakistani individuals, all of
whom do not have TTDN but 48 of whom have partially
overlapping phenotypes, i.e. intellectual disability, corneal
disease, nail dystrophy, and hair loss. The DMLE+ pro-
gram was used to estimate the age of the haplotype [17].
For haplotype age estimation, the following parameters
were used: autosomal recessive model of inheritance;
Pakistani population growth rate of 1.6 %, with an over-
all population of ~186,000,000; proportion of TTDN
phenotype as 1 per 1 million; proportion of the popula-
tion sampled at 7.5×10-8; 25-year intervals for each
generation; and interpolated map positions in cM using
the Rutgers combined linkage-physical map. A total of
1,000,000 burn-in iterations and 1,000,000 Markov chain
Monte Carlo iterations were run simultaneously, and
mean and 95 % confidence intervals (CI) for haplotype age
based on number of generations were calculated using the
last 10,000 iterations on each run.
Splicing assay
The MPLKIP gene was amplified using phusion high fidel-
ity DNA polymerase (New England Biolabs, MA, USA)
using the genomic DNA of a single affected (IV-1) and an
unaffected individual (IV-3) of family ED241, with forward
and reverse primers carrying the restriction sites for Not1
(5′ TGAGCTAGCATGCAGCGACAGAATTTTCGG 3′)
and Nhe1 (5′ TGAGCGGCCGCTGTTCCTGACACATG
AAGCTTCC 3′) respectively at 5′ tails. The mutant and
wild type amplicons were purified using the PCR purifica-
tion kit (QIAGEN, Hilden, Germany) and subcloned in
the topo vector using Zero blunt topo PCR Cloning Kit
(Invitrogen life sciences, Darmstadt, Germany) and trans-
formed into the One shot top10F* chemically competent
cells (Invitrogen life sciences, Darmstadt, Germany), pre-
ceded by overnight incubation at 37 °C after plating on
kanamycin-containing media. Next day the colonies con-
taining the clone of interest (verified by sequencing) were
processed for plasmid extraction using the QIAGEN mini
prep kit. Double digestion was done on 5 μg of extracted
plasmids and 2 μg of PCDNA3.1 by taking 15 units of
NOT1 and NHE1 in buffer 2.1 (New England Biolabs,
MA, USA) with a total volume of 100 μl at 37 °C for 2 h.
The double-digest products were gel-purified using the
QIAGEN QIAquick Gel Extraction Kit and processed for
overnight ligation reaction at 16 °C using a 1:4 ratio of
PCDNA3.1 and the mutant and wild type DNA in separate
reactions with a total volume of 10 μl using T4 DNA ligase
(Promega, Madison, USA). The ligated PCDNA3.1-mutant
MPLKIP and PCDNA3.1-wild type MPLKIP were trans-
formed again in One shot top10F* chemically competentcells, then incubated overnight at 37 °C after plating on
ampicillin-containing media. The colonies were sequenced
to verify the presence of the sequence of interest, followed
by plasmid extraction using the QIAGEN miniprep kit.
Prior to transfection, the HEK293 cells were seeded in a
12-well plate to make them at least 70 % confluent, follow-
ing 24 h of incubation at 37 °C in 5%CO2. Using standard
protocol 2 μg of extracted plasmids were introduced for
transfection using fugene HD transfection reagent (Pro-
mega, Madison, USA). The transfection of mutant and
wild typeMPLKIP constructs in HEK293 cells was done in
triplicate. Following 48 h of incubation at 37 °C in 5%CO2,
with change of media after the initial 24 h, the cells were
processed for RNA extraction using the QIAGEN Rneasy
Minikit. cDNA was synthesized using 1 μg of extracted
RNA random hexamer primers and M-MuLVreverse tran-
scriptase (New England Biolabs, MA, USA). The cDNA
was amplified using the MPLKIP-specific primer set used
for first amplification. PCR products were analyzed on 1 %
agarose gel stained with ethidium bromide. The amplified
products were purified using the QIAGEN QIAquick Gel
Extraction Kit and sequenced bidirectionally.
Results
All affected individuals of three families were born full-
term. The affected individuals presented with similar clin-
ical features of TTDN (Figs. 1, 2, Table 1), including: hair
abnormalities such as brittle hair, slow-growing sparse
scalp hair with patchy loss, sparse eyebrows, eyelashes and
body hair; aged appearance; recurrent rhinosinusitis; and
mild intellectual disability with slurred speech. Affected
adults were within the normal range for stature, while two
children ED241 IV-5 (12 year-old female) and ED210 IV-4
(8 year-old male; Table 1) were below 1 and 2 standard de-
viations, respectively, from the mean age-based height of
Pakistani children [18]. X-rays were not available to deter-
mine bone age for these two children. Polarized light mi-
croscopy of hair shafts from affected individual IV-2 of
family ED168 showed irregular surfaces and fractures
through the hair shafts and the characteristic tiger tail pat-
tern (Fig. 1c), which are suggestive of low sulfur content.
None of the affected individuals complained of UV sensi-
tivity or ichthyosis. Common facial characteristics among
affected individuals from these families include beaked
noses with crooked nasal bridges and seemingly flat malar
regions with either mandibular retrognathia or prognathia
(Figs. 1, 2). Additional features affecting nails, teeth and
eyes were identified in some but not all affected family
members (Table 1). Eight of nine affected individuals were
confirmed to have a high-arched palate, while only indi-
vidual IV-2 from family ED168 had a history of epilepsy
and corneal opacity upon ophthalmologic examination
(Table 1, Fig. 1c). On cardiac examination, all affected in-
dividuals were found to have mitral regurgitation, while
Table 1 Clinical features of individuals with nonphotosensitive trichothiodystrophy
Individuals ED168 ED210 ED241
IV-1 IV-2 IV-4 IV-6 IV-3 IV-4 IV-1 IV-2 IV-5
Gender Female Male Male Male Female Male Male Male Female
Age (years) 38 35 27 23 17 8 25 15 12
Height 5′4″ 5′8″ 5′6″ 5′6″ 4′9″ 3′4″a 5′7″ 5′1″ 4′5″a
Gestation Normal Normal Normal Normal Normal Normal Normal Normal Normal
Hair features
-Brittle hair Yes Yes Yes Yes Yes Yes Yes Yes Yes
-Dystrophic shaft Yes Yes Yes Yes Yes Yes Yes Yes Yes
-Hair growth Slow Slow Slow Slow Slow Slow Slow Slow Slow
-Diffuse hair fall Yes Yes Yes Yes Yes Yes Yes Yes Yes
Eyebrows Sparse Sparse Sparse Sparse Sparse Sparse Sparse Absent Absent
Eyelashes Sparse Sparse Sparse Sparse Sparse Sparse Sparse Absent Absent
Beard - Less dense Less dense Less dense - - Less dense - -
Aged appearance Yes Yes Yes Yes Yes Yes Yes Yes Yes
Intellectual disability Mild Mild Mild Mild Mild Mild Mild Mild Mild
Speech Slurred Slurred Slurred Slurred Slurred Slurred Slurred Slurred Slurred
Epilepsy No Yes No No No No No No No
Ocular features
-Blurred vision Yes Yes No No Yes Yes Yes Yes Yes
-Corneal bulging Yes Yes No No No No No No No
-Corneal opacity No Yes No No No No No No No
Recurrent rhinosinusitis Severe Severe Mild Mild Mild Mild Mild Mild Mild
High-arched Palate Yes ? Yes Yes Yes Yes Yes Yes Yes
Teeth Normal Normal Irregular, Hypodontia Normal Normal Irregular, Hypodontia Irregular Normal Normal
Skeletal structure Normal Normal Normal Normal Normal Normal Normal Normal Normal
Ichthyosis No No No No No No No No No
UV sensitivity No No No No No No No No No
Nails Normal Grooved Grooved Normal Thick Normal Dystrophic Dystrophic Dystrophic
Mitral regurgitation Yes Yes Yes Yes Yes Yes Yes Yes Yes
aHeight for these two children fall below 1–2 standard deviations from the mean for Pakistani children of similar age
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of three families (Figs. 1, 2) was unremarkable for any car-
diac abnormality including mitral regurgitation. Echocar-
diography performed on individuals IV-2 of family ED168
(Fig. 1c), IV-4 of family ED210 (Fig. 2c) and IV-2 of family
ED241 (Fig. 2e) confirmed the diagnosis of mitral regurgi-
tation in these affected individuals.
Using genome-wide genotypes from family ED168,
homozygosity mapping and linkage analysis identified a
16.17-Mb homozygous region between SNP markers
rs6959715 and rs12718947 on chromosome 7p14 (Fig. 1a),
with maximum multipoint LOD score of 3.26. From the
exome sequence data of ED168 IV-1, 63 homozygous vari-
ants were found within the homozygous region. Amongthe called variants, only one coding variant was not re-
ported in public databases, namely splice variant c.339 +
1G >A in the MPLKIP gene. Similarly from the exome se-
quence data of ED241 IV-2, the homozygous MPLKIP
splice variant was identified as the strongest candidate
among the observed variants. On the other hand, the
MPLKIP c.339 + 1G >A variant was not found in 218 in-
house exomes from unrelated non-TTDN Pakistani indi-
viduals or in Sanger sequence data from 284 Pakistani
control chromosomes.
The MPLKIP splice variant has a scaled CADD score
of 18.51, denoting that the variant is highly likely to be
deleterious. Functional analysis of the MPLKIP splice
variant c.339 + 1G > A confirmed pathogenicity at level
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to loss of the canonical splice donor site, consequently
resulting in retention of the intervening single intron of
969 bp (Fig. 1e). The resultant transcript featured with a
frameshift likely to result in formation of a truncated
MPLKIP protein of 131 amino acids as compared to its
wild type counterpart with 179 amino acids. Sanger se-
quencing of the splice variant in all available samples
from both families, ED168 and ED241, confirmed co-
segregation with the TTDN phenotype (Figs. 1a and b,
2a and b). Family ED210 was ascertained to have similar
TTDN features as family ED168, thus the two coding
exons of MPLKIP were sequenced using six DNA sam-
ples from family ED210. The same MPLKIP c.339 +
1G > A variant was found to co-segregate with TTDN in
family ED210 (Fig. 2a).
Comparison of four SNP genotypes surrounding the
MPLKIP gene revealed that affected individuals from
families ED168 and ED210 share a 4.13-Mb haplotype
from rs4723836 to rs10951731 (Fig. 2a), implicating the
splice variant might arise from a common founder.
Closer examination of the exome variants surrounding
the MPLKIP variant identified 14 SNPs that are homozy-
gous in both exomes from affected individuals ED168
IV-1 and ED241 IV-2 (Table 2). Using genotypes from
218 unrelated Pakistani individuals and the DMLE+ soft-
ware, the 585.1-kb haplotype was estimated to be at least
25,900 years old [95 % CI: 25,350-26,375].Table 2 Haplotype including homozygous exome variants from TTD
hg19
Position
Reference
Allele
Alternate
Allele
ExAC South
Asian MAF
Gene Varia
39606107 G A 0.10 YAE1D1 c.90
39608877 T C 0 YAE1D1 c.13
39609087 C G 0 YAE1D1 c.13
39609442 A T 0 YAE1D1 c.13
39610177 A G 0.10 YAE1D1 c.20
39610241 C G 0.11 YAE1D1 c.25
39611748 A G 0 YAE1D1 c.25
39611819 G A 0 YAE1D1 c.25
39856354 T C 0 NA NA
39874259 G A 0 NA NA
39874281 T C 0 NA NA
40087752 A G 0 CDK13 c.26
40117364 A G 0 CDK13 c.27
40173827 C T 0 MPLKIP c.33
40191226 C G 0 C7orf10 c.12
aBased on 218 in-house exomes from unrelated Pakistani individuals with non-TTDN
bThis YAE1D1 p.(Lys68Glu) variant is predicted to be benign by 9 out of 9 bioinform
cThe 3 exomes that are homozygous for this variant are from individuals with nons
NA, not applicableDiscussion
In this report we present three unrelated Pakistani families
with anMPLKIP splice variant co-segregating with TTDN.
To date at least 13 families and probands with TTDN
were identified to have homozygous or compound hetero-
zygous MPLKIP mutations. Of the identified mutations,
only one missense variant has been identified in an Amish
family [5], while truncating deletions were found in indi-
viduals of European, Middle Eastern or Moroccan descent
[19, 20]. The TTDN features identified in the three
Pakistani families reported here overlapped with clinical
findings in MPLKIP variant carriers with TTDN, par-
ticularly for hair abnormalities, intellectual disability
and susceptibility to infections. In the Pakistani fam-
ilies, variable features such as nail dysplasia, tooth ir-
regularities, facial characteristics, ocular disorders and
epilepsy were identified as well.
Notably all affected individuals from the Pakistani fam-
ilies have mitral regurgitation which is probably due to
cardiomyopathy, a feature that has not been reported as
part of the TTDN spectrum specifically caused byMPLKIP
mutations. In an earlier report, two Swiss sisters with
TTDN were documented to have dilated cardiomyopathy
with moderate mitral regurgitation [21], while a report on
two infants who died early due to TTDN described pul-
monic stenosis in both cases [22]. However we have no
means to verify whether these TTDN patients also carry
MPLKIP mutations. In a review of clinical findings inN families ED168 and ED241
nt Type #Heterozygousa #Homozygousa
G > A synonymous 41 3
0 -1228 T > C intronic 0 0
0 -1018C > G intronic 0 0
0 -663A > T intronic 0 0
2A > Gb missense 41 3
1 + 15C > G intronic 13 0
2 -128A > G intronic 0 0
2 -57G > A intronic 0 0
intergenic 1 0
intergenic 28 11
intergenic 28 11
00 + 276A > G intronic 0 3c
81 -240A > G intronic 1 0
9 + 1G > A splice 0 0
1 + 16507C > G intronic 1 0
phenotypes
atics prediction tools from dbNSFP
yndromic hearing impairment
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but some patients clearly have TTD rather than TTDN,
while in other reports the presence or absence of photo-
sensitivity was not documented [1]. In other cases, the
heart defect was ruled out at autopsy or deemed coinci-
dental e.g. murmur due to sideroblastic anemia, or isolated
congenital heart defects which have a much higher inci-
dence than TTD or TTDN [1, 21, 23]. For families ED168
and ED241, across the exome the MPLKIP splice mutation
is the only rare homozygous variant that is predicted to be
deleterious or damaging and this variant segregates with
both TTDN and mitral regurgitation, supporting the inclu-
sion of cardiomyopathy as a feature of TTDN due to
MPLKIP variants. Additionally the variant occurs within a
small founder haplotype that is shared by the two families,
which further strengthens the evidence that the same
founder variant is responsible for the rare TTDN pheno-
type including the cardiomyopathy.
MPLKIP binds to serine/threonine kinase PLK1, which
plays critical roles in multiple cell cycle events, including
mitotic entry, centrosome maturation and separation,
spindle pole integrity, kinetochore attachment, and cyto-
kinesis [24, 25]. MPLKIP colocalizes with PLK1 during
mitosis, and overexpression or inhibition of MPLKIP re-
sults in nuclear fragmentation or disrupted mitotic spin-
dles, suggesting the importance of PLK1 regulation by
MPLKIP in cell cycle maintenance [26]. Phosphorylation
of MPLKIP by CDK1 at multiple serine or threonine res-
idues is required for interaction of MPLKIP with PLK1
[26]. While both MPLKIP and PLK1 are expressed in
multiple tissues that are affected by TTDN including
brain, lung, heart and skin [5, 6, 27], we did not identify
TTDN phenotypes affecting organs where adult expres-
sion of MPLKIP is highest, such as in liver, kidney, skeletal
muscle and pancreas [6]. On the other hand, MPLKIP is
expressed in fetal skin and fibroblasts [5], while PLK1 ex-
pression is highest in tissues with actively proliferating
cells (e.g. gonads, cancers) [27]. PLK1 is also expressed in
neural progenitor cells and gradually diminishes during
neurogenesis [28], but is increased in brain cells of Alzhei-
mer disease patients [29]. Similarly in heart, expression of
PLK1 mRNA and protein progressively decreases during
development and disappears in the adult [30], but is up-
regulated in cardiomyocytes during regeneration post-
injury [31]. The unusual splicing due to the MPLKIP
splice variant as validated by the splice assay confirmed
formation of a frameshift transcript due to a retained in-
tron (Fig. 1e). The transcript with premature termination
signal at codon 132 is predicted to result in the loss of a
putative phosphorylation site at Ser133. The loss of the
phosphorylation site is expected to underlie the TTDN
pathogenesis observed in our families. Taken together this
evidence suggests that non-functional MPLKIP due to
protein truncation and non-phosphorylation might lead tofailed interaction of MPLKIP with PLK1, which plays a
role in development of various organs including skin,
brain and heart.
Conclusion
Overall our study expands the allelic and phenotypic spectra
of MPLKIP-related TTDN, to include a splice variant that
causes cardiomyopathy as part of the TTDN phenotype.
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